London-based Bioniq, a company that claims to make the world’s most personalised supplements based on blood biomarker data, has secured €1M from football star Diogo Dalot, right-back for Manchester United and the Portugal national team.
“Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalised nutrition,” adds Dalot.
The announcement comes six months after Cristiano Ronaldo made a significant investment in the company, bringing its total valuation to $82M.
Diogo Dalot’s personalised supplements
Diogo Dalot has been a dedicated Bioniq member for over four years.
He has integrated the Bioniq formula into his daily routine to optimise health and performance.
With Bioniq’s hyper-personalised supplement — Build Your Own, Dalot has created an even more precise supplement routine, allowing him to vary his nutrient intake based on his performance goals.
“While the PRO formula is designed to reduce inflammation, increase resilience, and improve endurance, his adjunct Build Your Own allows mild inflammation as a natural part of the muscle-building process. When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalized and tailored specifically to my needs,” says Diogo Dalot.
Today, products are available for customers from 70 countries, with its total user base growing more than 10x in 2024, claims the company.
The UK company stands at the forefront of the rapidly expanding supplements market, which was valued at $177.50B in 2023 and is projected to grow at a CAGR of 9.1 per cent from 2024 to 2030.
Bioniq: World’s most personalised supplements
Launched in 2019, Bioniq offers AI-driven personalised supplements based on blood test data.
With the largest proprietary biochemical database from customers across five continents, Bioniq has created formulas for over 300,000 users, tailored to their nutrient deficiencies.
The company offers two distinct approaches to personalised health optimisation.
Bioniq PRO provides high-level personalisation by incorporating blood biomarker data, allowing users to upload existing bloodwork or book tests through partner labs.
This data is used to tailor daily supplements and includes consultations with a Registered Dietitian.
For a more accessible option, Bioniq GO uses a questionnaire to recommend supplement blends based on the AI algorithm and previous users’ blood data.
Both options leverage Bioniq’s extensive proprietary biochemical database to optimise individual health.
The company’s Swiss-made, pharmaceutical-grade supplements are custom-formulated with precise micro-dosing to meet individual needs.
Each formula includes a mix of antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fiber.
Delivered in patented prebiotic guar granules instead of traditional pills, these supplements enhance nutrient absorption by mimicking natural digestion.
The company’s data-driven approach and quantifiable results have attracted partnerships with leading health and sports institutions such as Lanserhof and UFC and have become the preferred choice for top athletes like Manchester United’s Diogo Dalot and former NBA All-Star Andrei Kirilenko.
“Diogo has an exceptional approach to performance optimisation and recovery, constantly seeking the most effective and scientifically backed methods to enhance his physical and cognitive capabilities,” says Vadim Fedotov, Founder and CEO of Bioniq.
“His dedication to craft and commitment to maximising potential makes him a perfect fit for Bioniq. He shares our vision and mission, recognising that the future of health lies in precision, personalisation, and efficacy. His investment is yet another testament to this shift — where science-driven, individualised solutions create meaningful impact in the industry and everyday well-being,” adds Fedotov.